Finasteride, dutasteride, minoxidil, PRP, microneedling, transplants. The math of male pattern hair loss, the meds that bend it, and the things sold to you that mostly do not.
Hair loss is mostly a DHT story, and DHT is mostly a story your DNA wrote before you were born. The follicles on the top of your scalp are genetically sensitive to dihydrotestosterone, the more potent androgen your body makes by converting regular testosterone with an enzyme called 5-alpha reductase. Over years, that sensitivity miniaturizes those follicles, the hair shafts come in finer, the growth cycles get shorter, and eventually the follicles stop producing visible hair altogether. The follicles on the sides and back of your scalp are genetically less sensitive to the same hormone, which is the whole reason hair transplants work, the surgeon is moving DHT-resistant follicles into the DHT-affected zone and those follicles keep behaving the way they were programmed to behave regardless of their new address.
The thing I want to say at the top, because everything else in this post depends on it, is that the treatments work and the math is on your side if you start early. That is the whole shape of the conversation. Hair loss treatment is one of the most evidence-based areas in men’s health, the drugs have decades of data behind them, the protocols are well-defined, and the response rates are honestly pretty good for guys who actually do the work. The choices that matter, and they are choices, are starting before you can see scalp through the front, staying on the meds for years and not weeks, and not falling for the supplement marketing that wants you to believe biotin gummies are going to do anything for you. None of the meds bring back what has been gone for years. The meds slow what is still happening and sometimes regrow what is recent. That distinction decides whether starting today is going to pay off, and it usually does pay off if you start today rather than three years from now.
Finasteride, the gold-standard maintenance drug
Finasteride is an oral 5-alpha reductase inhibitor, originally developed for benign prostate enlargement at 5mg, then re-labeled at 1mg for androgenetic alopecia (the medical name for male pattern baldness) after the cosmetic effect on hair turned out to be more interesting than the prostate effect for most patients. The mechanism is exactly what it sounds like, the drug blocks the enzyme that converts testosterone to DHT, scalp DHT levels drop by something like 60 to 70 percent on the 1mg dose, the follicles get less of the signal that has been miniaturizing them, and the miniaturization process slows or reverses depending on how far along it had gotten.
The numbers from the original Merck trials and the ten and twenty year follow-up data are, by drug-trial standards, kind of remarkable. Somewhere between 80 and 90 percent of men on finasteride stop losing hair, meaning the photographic progression that was going to happen over the next five years simply does not happen, or happens much more slowly. Around 30 to 50 percent see modest regrowth at one to two years, the front and crown filling back in to some degree, the photos at year two genuinely better than the photos at baseline. The regrowth is real, it is not dramatic for most people, and it is not a substitute for not losing more in the first place. The big win is the slow-down. The regrowth is the bonus you get for starting before you needed the drug for cosmetic recovery.
The dosing is one milligram daily, taken at any time of day, with or without food, for as long as you want to keep your hair. That last part is the part people miss. The drug is suppressing an enzymatic process that wants to keep running. The day you stop the drug, the suppression stops, scalp DHT comes back up, and within six to twelve months the miniaturization picks up where it left off, plus the regrowth you got typically slides back out over the same window. There is no graduation. There is no point at which the drug has cured the underlying genetic sensitivity. If we are being honest, this is a chronic medication for a chronic biological pattern, and the patients who do best with it are the ones who internalized that fact at the start and stopped looking for an exit.
Dutasteride, the bigger hammer
Dutasteride is the same idea with a bigger swing. Where finasteride blocks the type 2 isoform of 5-alpha reductase, dutasteride blocks both type 1 and type 2, which means scalp DHT drops by around 90 percent instead of 70, and the regrowth signal in head-to-head trials runs a little stronger. It is FDA-approved for prostate enlargement in the US under the brand name Avodart, and it is on-label for androgenetic alopecia in Korea and Japan but used off-label for it everywhere else. The off-label status in the US is a paperwork issue, not a data issue. The data is good, the prescribing pattern is established, and any psychiatrist or dermatologist who treats men’s hair loss is comfortable writing it when the situation warrants.
The dosing is half a milligram daily, sometimes stepped down to half a milligram three times a week once the effect is established, since the half-life is genuinely long (around five weeks) and the receptor blockade outlasts the dosing interval by a wide margin. Patients who plateau on finasteride at one or two years sometimes get an additional 0.5 to 1 point of improvement on a Norwood score (the scale dermatologists use to grade how far hair loss has progressed) by switching to dutasteride. The side-effect signal is in the same shape as finasteride and a little louder, which is the trade-off you take for the stronger DHT suppression. Whether the trade is worth it depends on how much room you have to lose, how the finasteride trial went, and how risk-tolerant you are about the side-effect conversation we are about to have.
The finasteride side-effect conversation, the honest version
This is the conversation that derails people, and it deserves an honest treatment rather than the dismissive “side effects are rare, here is your prescription” line a lot of prescribers default to. The sexual side effects that show up in the trials and in clinical practice are reduced libido, erectile difficulty, and decreased ejaculate volume. The trial numbers run in the low single digits, somewhere between one and four percent for each item, with the placebo arm reporting similar items at rates that are not zero either, which complicates the math. What that means is that for the average patient population, the risk is small. What that means for you, the specific person reading this, is that the risk is binary, you either get the side effect or you do not, and “two percent” is not a number you can feel.
The bigger and messier conversation is post-finasteride syndrome, the controversial cluster of persistent sexual, mental, and physical symptoms that some men report continuing after they stop the drug. The advocacy community for PFS is loud, the medical community is more divided, and the data is genuinely complicated. The honest read is that most reported side effects do reverse on discontinuation within a few months, that a small subset of patients report symptoms that persist longer, and that the mechanism for true persistent symptoms is not well understood. Whether you call that a real syndrome or a constellation of nocebo effects and unrelated symptoms attributed to the drug depends on which papers you read and how you weigh case reports against trial data. I am not going to pretend the question is settled, because it is not.
What I tell patients is the thing I would want said to me if the roles were reversed. The drug works, the population-level risk is small, the individual risk is binary, and the way we manage it is by starting and watching. If you are going to be on finasteride, you start it, you pay attention, and if anything shifts in the first few months you tell me and we stop. Most patients never have a problem. A small number do, and the ones who stop early almost always return to baseline. The reason to have this conversation up front is so that if anything does shift, you catch it at week eight instead of grinding through it for two years because you assumed it was unrelated. That is the deal. Anyone telling you the drug is completely safe is a damn liar, and anyone telling you it is too risky to consider is ignoring the largest body of data we have on any hair loss drug.
The drug works, the population-level risk is small, the individual risk is binary, and the way we manage it is by starting and watching.
Minoxidil, the other half of the protocol
Minoxidil is a different drug doing a different thing, and it stacks on top of the DHT blockade rather than replacing it. The mechanism is partly vasodilation (the drug widens small blood vessels in the scalp, originally noticed when it was being used as an oral blood pressure med and patients started growing extra body hair as a side effect) and partly a more direct effect on the follicle, pushing follicles from their resting telogen phase into the active anagen growth phase earlier than they would have on their own. The topical 5 percent foam or solution, applied twice daily to the affected scalp, has been the standard for thirty years. The catch with topical minoxidil has always been adherence, twice-daily greasy scalp application is a habit a lot of guys lose within six months, and the drug only works while you are using it, so the drop-off rate has been the limit on real-world effectiveness for a long time.
The big shift in the last few years has been low-dose oral minoxidil, originally a blood pressure drug, now being prescribed off-label at 2.5 to 5mg daily for hair loss. Adherence is dramatically better because it is a once-daily pill instead of a twice-daily scalp ritual, and the response in the trials and the real-world data has been at least as good as topical, sometimes a little better. The trade-offs are real. The drug can drop blood pressure, which is a feature if you have high blood pressure and a bug if you do not, so a baseline blood pressure check and a follow-up at four to six weeks is part of the protocol. The other common side effect is increased body and facial hair, which is great if you want a thicker beard and frustrating if you do not, particularly in patients who already have heavy facial growth. There is a small but real signal for fluid retention and ankle swelling at the 5mg dose, mostly fixed by dropping to 2.5mg. None of this is exotic, and the prescribing pattern in dermatology has shifted toward oral minoxidil as the default over the last few years because the adherence advantage is so large.
The big three protocol
The combination that does the most for the most patients is finasteride plus minoxidil plus a ketoconazole shampoo, the so-called big three. Finasteride is suppressing the DHT signal that is driving the miniaturization. Minoxidil is pushing the follicles into the active growth phase and keeping them there. Ketoconazole shampoo, the over-the-counter Nizoral 1 percent or the prescription 2 percent used two or three times a week, is doing two things at once, treating the low-grade seborrheic dermatitis a lot of guys with hair loss have without realizing it, and providing a mild secondary anti-androgen effect at the level of the scalp follicle itself. The shampoo on its own is not a hair loss treatment. As an adjunct to the other two, it adds a small but real increment, and it is cheap enough that there is no reason to skip it.
The trial data on combination therapy is consistently better than the data on any single agent. The numbers from the combination studies show roughly 90 percent of patients stabilizing or improving at one year, compared to roughly 80 percent on finasteride alone or 60 percent on minoxidil alone. The increments stack rather than compete, which is what you would expect when the drugs are working on different parts of the same biology. The protocol I run with patients who want the most aggressive medical approach short of dutasteride is finasteride 1mg daily, oral minoxidil 2.5mg daily, ketoconazole shampoo two to three times a week, and a six-month photograph appointment to see what is actually happening before we make any further changes. The photographs matter because the day-to-day mirror is a terrible instrument for tracking hair, you live with your own face and you do not see the slow regrowth, but a side-by-side at six months will usually show you something.
PRP, the expensive adjunct
Platelet-rich plasma is the procedure where the clinician draws a tube of your blood, spins it down in a centrifuge to concentrate the platelets, and injects the platelet-concentrated layer into the scalp where hair is thinning. The mechanism is presumed to be the growth factors that platelets release when they activate, the same biology that drives wound healing, applied to the follicle environment to stimulate regrowth. The evidence base has gotten more respectable over the last five years, with multiple decent randomized trials showing real improvement in hair density and follicle count at six and twelve months when PRP is done as a series of three or four sessions a month apart, followed by maintenance every four to six months.
The honest framing is that PRP is a respectable adjunct, not a standalone, and the price point puts it in a different category from the meds. A series of sessions runs somewhere between two and five thousand dollars depending on the market, and maintenance is an ongoing cost rather than a one-time investment. For a patient who is already on the medical protocol, doing the work, and looking for the additional increment that pushes the result from good to better, PRP is reasonable. For a patient who is hoping PRP is going to substitute for the daily meds, it is not going to do that, and the better money is on the cheaper drugs. The other reasonable use case is the patient who genuinely cannot tolerate finasteride and wants to do what they can without the systemic DHT blockade, where PRP plus topical minoxidil plus microneedling is a viable, if less effective, plan B.
Microneedling, the cheap adjunct that actually works
Microneedling is a derma-roller with 1.5mm needles, rolled over the affected scalp once or twice a week, creating thousands of microscopic punctures that trigger a collagen and growth-factor response and also dramatically improve the penetration of topical minoxidil applied after the rolling. The evidence base is honestly better than people expect. Multiple trials have shown that microneedling plus topical minoxidil outperforms topical minoxidil alone by a meaningful margin, with the regrowth numbers at six months running closer to what you would expect from the big three protocol. The cost of the device is something like twenty to forty dollars one time, and the time cost is a few minutes a week, which makes the cost-benefit math hard to argue with.
The technique matters. The 1.5mm needle length is the one with trial data behind it, the shorter lengths sold for general skin use are not deep enough to do the follicle work, and the longer lengths are unnecessary and add risk of bleeding and infection. The rolling pattern is a grid, vertical then horizontal then diagonal, light pressure rather than aggressive grinding, until the scalp is mildly pink and you can feel the heat. Topical minoxidil goes on after, not before, because the punctures are the absorption route the protocol is taking advantage of. Do not roll over active acne or any broken skin, do not roll a scalp that just had PRP done, and let the skin recover for a day between sessions. The combination of microneedling plus topical minoxidil is the cheapest serious adjunct on the menu, and it is the one I will mention first when a patient is on finasteride and wants to do more without spending more.
Hair transplant, when it makes sense
The surgical option is hair transplantation, either FUE (follicular unit extraction, where individual follicles are punched out of the back of the scalp and placed individually into the recipient area) or FUT (follicular unit transplantation, the older strip-harvest technique that leaves a linear scar at the donor site and is mostly displaced by FUE now). The underlying logic is the same one we started with, the follicles at the back of the scalp are genetically DHT-resistant, so when you move them to the front they keep behaving like back-of-scalp follicles and they keep growing. The surgical result, when done well by a real surgeon working with realistic hairline design and adequate graft counts, can be transformative, the keyword being when done well.
The decision math for transplant comes down to two questions. First, have you done a real trial of medical management, meaning at least a year on finasteride and minoxidil, and what does the result look like, because medical management can spare you the surgery entirely or at minimum reduce the graft count you need. Second, are you committed to staying on the medical protocol after the surgery, because the follicles that are still in place around the transplanted grafts are still genetically susceptible to DHT and they will keep miniaturizing if you are not treating them, which produces the worst possible cosmetic outcome where the transplanted hair stays put and the surrounding native hair keeps thinning, leaving an awkward island of density. Anyone offering you a transplant without insisting on medical management before and after is in the wrong business, and any patient walking into a transplant with the idea that the surgery is the whole treatment is signing up for a disappointing two year window.
The supplements that do not work
Most of the supplement aisle is selling you nothing. Biotin is the loudest example, sold in gummies and capsules at hundreds or thousands of times the actual daily requirement, on the theory that more biotin will produce more hair. Biotin deficiency does cause hair loss. You almost certainly do not have biotin deficiency, which is rare outside of specific medical conditions, certain medications, and prolonged raw egg white diets that block biotin absorption. Supplementing biotin when you are not deficient does not do anything for your hair, and at very high doses it can actually interfere with several common lab assays including thyroid panels and cardiac troponins, which is the part the marketing leaves out. If your dermatologist or psychiatrist is ordering labs and you are on high-dose biotin, you tell them, because the labs will read wrong and the troubleshooting wastes everyone’s time.
Saw palmetto and other plant-derived “natural DHT blockers” have a tiny body of small studies suggesting a mild effect, much weaker than finasteride, at doses that are not standardized across the over-the-counter market. The honest read is that the evidence is not strong enough to recommend the supplement as a treatment, and that anyone advertising saw palmetto as a finasteride alternative is overstating the data. If you genuinely cannot take finasteride and you want to do something on the DHT axis, the medical answer is topical finasteride (a compounded preparation that targets the scalp follicle with less systemic absorption) rather than saw palmetto, which sits closer to wishful thinking than to treatment. The “hair growth” topicals that are not minoxidil, the rosemary oils, the caffeine shampoos, the peptide serums, are mostly in the same category. Some have a small signal in a small study somewhere. None of them are in the same league as the drugs we actually have, and most of them are charging premium prices for ingredients with very thin evidence.
The TRT and hair loss interaction
If you are on testosterone replacement therapy, or you are about to start, the hair loss conversation is part of the package whether your TRT prescriber brought it up or not. More testosterone means more substrate for 5-alpha reductase, which means more scalp DHT for genetically susceptible follicles, which means that patients who were going to lose hair eventually often lose it faster on TRT than they would have lost it without. The signal varies, some guys notice nothing, some guys notice rapid thinning within the first six months of starting testosterone, and the difference is largely about how DHT-sensitive their follicles were in the first place. The genetic susceptibility is the same, the substrate availability is what changed.
The standard move for patients on TRT who want to protect against the hair loss acceleration is to add finasteride to the regimen at the same 1mg dose. The DHT blockade does not interfere with the testosterone effects you are taking the TRT for in the first place, since the muscle-building, mood-improving, libido-restoring effects of testosterone are largely driven by testosterone itself and by aromatization to estradiol rather than by DHT specifically. What you lose by adding finasteride is the DHT contribution to scalp hair loss and a small amount of the DHT contribution to other androgenic effects, which for most guys is a trade they are happy to make. The conversation worth having with the prescriber is whether to start finasteride preemptively when you start TRT or to wait and see whether you start losing hair first, and the answer depends on family history, current hair status, and how much regret you would have if you waited and lost half an inch of frontal hairline before you started treating it.
Pattern recognition, what early loss actually looks like
The signs of early androgenetic alopecia are subtle, and they are the signs you want to catch, because the meds work best when the follicles are still alive and producing some hair, even thinned hair, rather than gone entirely. Recession at the temples, the front hairline moving back a quarter or half inch and forming the slight M shape that everybody recognizes once they see it on themselves, is usually the first sign. Crown thinning, where the scalp at the back top of the head starts showing through in certain lighting or in the post-shower photograph somebody else took of you that you did not expect, is the second. The hair coming in shorter and finer after a haircut, the texture changing, the wet-hair density obviously different than it was a year ago, are the subtler signs that often precede visible loss by another year or two.
The “too late” signs are the ones where the medical management can stabilize what is left but cannot get back what is gone. A slick crown with no visible follicles in the bald area, frontal scalp visible through the hair at any angle in normal indoor light, miniaturized follicles that have not produced a visible hair in years, are all signs that the follicles in those areas have moved past the point where finasteride and minoxidil are going to rebuild anything substantial. The meds will still help by protecting whatever is still alive at the borders and whatever is still alive elsewhere on the head, which is worth doing, but the cosmetic recovery is going to require a transplant if it is going to happen at all. The reason to start before you hit that point is that the meds get less effective as the loss advances, the regrowth window narrows, and the same drug that would have stabilized you at twenty-six is offering you much less at thirty-eight when the follicles you needed it to protect are no longer there.
The cost of starting two years too early is much smaller than the cost of starting two years too late.
Where this all lands
Hair loss treatment is one of the most evidence-based areas in men’s men’s health, the drugs work, the protocols are well-defined, and the response rates for patients who start early and stay consistent are good. The math is on your side if you start when you first notice the change, if you stay on the meds for years rather than weeks, and if you accept that the drugs are doing a chronic suppression job on a chronic biological pattern rather than performing a one-time fix. The meds do not do the work alone, you have to actually take them, daily, for years, and the patients who do best are the ones who built the daily habit early and stopped looking for a permission slip to stop.
If we are being honest, the supplement aisle, the gummy subscriptions, the rosemary oils, the laser caps with two small studies behind them, are mostly noise that exists because the real treatments are unsexy and require you to take a generic pill every day for the rest of your life. The actual answer is unglamorous. Finasteride, minoxidil, ketoconazole shampoo, microneedling if you want to push the result, PRP if you have the money and want to push it further, transplant if you have advanced loss and a real maintenance plan. That is the menu. Everything else is selling you something you do not need. The choices are yours, the math is in your favor if you start early, and the work the drugs cannot do for you is the work of actually taking them, day after day, for as long as you want to keep what you have.
Sources
FDA prescribing information for Propecia (finasteride 1mg), Proscar (finasteride 5mg), Avodart (dutasteride), Rogaine (topical minoxidil 5%), and Loniten (oral minoxidil). Kaufman KD et al., finasteride in the treatment of men with androgenetic alopecia, J Am Acad Dermatol 1998, 39(4 Pt 1), 578 to 589 (PMID 9777765). Olsen EA et al., global photographic assessment of men with male pattern hair loss receiving finasteride 1mg or placebo, J Am Acad Dermatol 2012, 67(3), 379 to 386 (PMID 22325459). American Academy of Dermatology (AAD) position statements on androgenetic alopecia. van Zuuren EJ et al., interventions for female pattern hair loss, Cochrane Database of Systematic Reviews 2016, CD007628 (PMID 27225981), the only Cochrane systematic review of pattern hair loss interventions, female only. Randolph M and Tosti A, oral minoxidil for hair loss, a review of efficacy and safety, J Am Acad Dermatol 2021, 84(3), 737 to 746 (PMID 32622136). Dhurat R et al., a randomized evaluator-blinded study of microneedling in androgenetic alopecia, Int J Trichology 2013, 5(1), 6 to 11 (PMID 23960389). Gupta AK and Carviel JL, meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia, J Dermatolog Treat 2017, 28(1), 55 to 58. American Hair Loss Association consumer materials. Eun HC et al., efficacy, safety, and tolerability of dutasteride 0.5mg once daily in male patients with male pattern hair loss, J Am Acad Dermatol 2010, 63(2), 252 to 258 (PMID 20605255).